Full Text
PSY27 Cost Effectiveness of Treatment With Etanercept or Ustekinumab for Moderate to Severe Psoriasis

Abstract

Authors

R. Villacorta J. Hay A. Messali

Back to Volume 15, Issue 4
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×